This guide is continuously monitored and updated by our AI compliance engine. It tracks legislative changes, board rulings, and regulatory updates for Utah in real time — so you always have the most current compliance intelligence.
The telehealth compliance information for Utah presented on this page is provided for general informational purposes only and should not be construed as legal advice. The telehealth regulatory landscape is evolving rapidly, with state legislatures, medical boards, and federal agencies frequently updating rules, guidance, and enforcement priorities. While TrueEval makes every effort to keep this information current and accurate, we cannot guarantee that all details reflect the very latest regulatory changes at the time of your visit.
We strongly recommend consulting with a qualified healthcare attorney or compliance professional before making business decisions based on this information. For the most current regulatory requirements, refer directly to your state medical board and relevant licensing authorities. Last reviewed: February 2026.
Utah presents a generally favorable regulatory environment for healthcare companies, balancing patient protection with a pragmatic approach to innovation, particularly in telehealth. The state has actively embraced telehealth as a means to expand access to care, evidenced by its comprehensive telehealth parity laws and relatively clear guidelines for remote service delivery. Key regulatory bodies include the Utah Division of Occupational and Professional Licensing (DOPL), which oversees professional licensing boards (e.g., Medical Board, Osteopathic Medical Board, Board of Nursing, Pharmacy Board), and the Utah Department of Health and Human Services (DHHS). The general business climate is considered pro-business, with a focus on efficiency and technological advancement. Recent legislative actions have primarily focused on refining telehealth definitions, ensuring payment parity, and addressing specific prescribing challenges, particularly for controlled substances. Utah's regulatory framework aims to facilitate care delivery while maintaining high standards of professional conduct and patient safety. Companies looking to expand into Utah will find a clear, albeit detailed, path to compliance, requiring careful attention to licensing, scope of practice, and the nuances of telehealth-specific regulations. The state's approach is often characterized by a willingness to adapt to new healthcare models, making it an attractive market for innovative healthcare providers, including those in the medspa, IV therapy, and wellness sectors, provided they navigate the specific professional licensure and corporate practice restrictions.
Utah maintains a robust Corporate Practice of Medicine (CPOM) doctrine, which generally prohibits corporations, entities, or individuals who are not licensed healthcare professionals from employing physicians or controlling the practice of medicine. The legal basis for Utah's CPOM doctrine is primarily derived from common law and reinforced by various statutes that define the practice of medicine and prohibit unlicensed practice. Utah Code Ann. § 58-67-801, for instance, makes it unlawful for any person to practice medicine without a license. While there isn't a single overarching statute explicitly stating 'no corporate practice of medicine,' the cumulative effect of licensing laws and professional practice acts creates a strong prohibition. Non-physicians are generally prohibited from owning medical practices or directly employing physicians. This extends to other licensed professions, such as dentistry (Utah Code Ann. § 58-69-801) and chiropractic (Utah Code Ann. § 58-73-801). The primary exception to this rule is for professional corporations (PCs) or professional limited liability companies (PLLCs) formed by licensed professionals, where ownership is restricted to licensed individuals within that profession (Utah Code Ann. § 16-11-1 et seq. for PCs, and Utah Code Ann. § 48-3a-101 et seq. for PLLCs). These entities must register with DOPL. For telehealth companies, medspas, dental practices, and wellness clinics, this means that the clinical entity providing professional services must be owned and controlled by licensed professionals. Non-clinical functions, such as marketing, billing, and technology, can be managed by a separate management services organization (MSO) under a Management Services Agreement (MSA). However, the MSA must be carefully structured to avoid any perception of control over clinical decision-making or fee-splitting that violates professional ethics or anti-kickback statutes. Specifically, the MSO cannot dictate patient care, hire/fire clinical staff (beyond administrative functions), or receive a percentage of professional fees. Medspas, in particular, face scrutiny regarding the delegation of medical procedures to non-physicians and the ownership structure. All medical procedures must be performed under the supervision of a licensed physician, and the entity itself must comply with CPOM. Similarly, IV therapy and wellness clinics offering medical services must adhere to these ownership and control restrictions. Utah's CPOM enforcement is considered moderately strict, with DOPL actively investigating complaints related to unlicensed practice and improper corporate structures. Companies must ensure their organizational documents and operational agreements clearly delineate the separation between professional medical services and administrative support functions to mitigate CPOM risks.
Utah has a progressive stance on telehealth, with comprehensive legislation ensuring its integration into the healthcare delivery system. The establishment of a valid provider-patient relationship via telehealth is explicitly permitted. Utah Code Ann. § 26B-4-201 defines 'telehealth' broadly as the use of electronic information and communication technologies to provide health care services, including diagnosis, consultation, treatment, education, care management, and self-management, while the patient is at an originating site and the healthcare provider is at a distant site. A provider-patient relationship can be established through telehealth without a prior in-person visit, provided the standard of care is met. This is a crucial point for direct-to-consumer telehealth models. All modalities are generally permitted, including live interactive audio-visual (video), interactive audio-only (phone), and asynchronous (store-and-forward) technologies, as long as they are appropriate for the service being rendered and meet the standard of care. Utah Code Ann. § 26B-4-203 mandates that a health care provider providing telehealth services must meet the same standard of care as if the health care services were provided in person. There are no specific telehealth registration requirements for providers beyond their standard professional licensure with DOPL. However, providers must be licensed in Utah to provide services to patients located in Utah. Informed consent for telehealth services is required. While not explicitly detailed in statute for every scenario, general informed consent principles apply, and providers should ensure patients understand the nature of telehealth, its limitations, privacy considerations, and how to access follow-up care. Many boards, such as the Utah Medical Board, emphasize the importance of appropriate informed consent. There are no specific geographic restrictions within Utah for telehealth services; providers can treat patients anywhere within the state. However, providers must be physically located in a state where they are licensed to practice when delivering telehealth services to Utah patients. Out-of-state providers must obtain a Utah license to treat Utah residents, even via telehealth. Utah Code Ann. § 26B-4-202 outlines requirements for health benefit plans to cover telehealth services at the same level as in-person services, promoting payment parity. This favorable regulatory environment makes Utah attractive for telehealth expansion, but strict adherence to licensing, standard of care, and informed consent remains paramount.
Prescribing controlled substances via telehealth in Utah is permissible but subject to stringent federal and state regulations. For non-controlled substances, prescribing via telehealth generally follows the same rules as in-person prescribing, provided a valid provider-patient relationship is established and the standard of care is met. For controlled substances, Utah aligns with federal DEA requirements. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person medical evaluation before prescribing controlled substances via the internet. However, there are exceptions, notably the 'telemedicine exception,' which allows for prescribing if the practitioner has conducted an in-person medical evaluation or is practicing in a DEA-registered hospital or clinic, among other scenarios. During the COVID-19 Public Health Emergency (PHE), the DEA waived the in-person requirement, allowing for audio-visual telehealth prescribing of controlled substances. While the federal PHE ended, the DEA has issued proposed rules to establish permanent telemedicine flexibilities for controlled substance prescribing. As of early 2025, the DEA has extended the full set of COVID-19 telemedicine flexibilities through December 31, 2024, and for practitioners who established a telemedicine relationship on or before December 31, 2024, through December 31, 2025. After this period, the in-person requirement is expected to return unless new federal rules are finalized. Utah law, specifically Utah Code Ann. § 58-17b-603, outlines requirements for prescribing, dispensing, and administering controlled substances, including the need for a legitimate medical purpose and within the usual course of professional practice. Utah also mandates checking the Controlled Substance Database (CSDB), its Prescription Drug Monitoring Program (PDMP), for Schedule II, III, IV, and V controlled substances prior to prescribing. Utah Code Ann. § 58-37-6.5 requires practitioners to review the CSDB before prescribing an opioid or benzodiazepine to a patient for the first time, and then periodically thereafter. There are no specific quantity or refill limitations unique to telehealth prescribing beyond those applicable to in-person prescribing. However, practitioners must exercise professional judgment and adhere to best practices for safe prescribing. For specific drug classes like GLP-1s, testosterone, and stimulants, the standard of care and medical necessity are paramount. Prescribing stimulants, particularly for ADHD, often involves more rigorous evaluation requirements, sometimes including psychological testing, which can be challenging to fully replicate via telehealth without careful protocols. Similarly, testosterone therapy requires thorough evaluation and monitoring. GLP-1s, while not controlled substances, require careful patient selection and monitoring for side effects. Providers must ensure their telehealth platform and protocols support these requirements. Any prescribing of controlled substances via telehealth must be done using an electronic prescribing for controlled substances (EPCS) system, as mandated by federal and state regulations.
Utah's scope of practice laws delineate the services that various licensed healthcare professionals can legally perform. For Advanced Practice Registered Nurses (APRNs), Utah has moved towards granting significant autonomy. Utah Code Ann. § 58-31b-102 defines an APRN as an individual licensed by the state as a registered nurse and who has completed an accredited graduate-level education program. While Utah does not grant 'full practice authority' in the sense of complete independence from physician oversight for all APRN roles, it provides a pathway to increased autonomy. Specifically, Utah Code Ann. § 58-31b-301(2)(b) allows for certain APRNs (e.g., Nurse Practitioners, Clinical Nurse Specialists) to practice without a specific delegation or supervision agreement with a physician after completing a period of supervised practice (e.g., 2,000 hours and two years of full-time clinical practice) and fulfilling other requirements, such as obtaining a 'controlled substance license' if prescribing. Prior to meeting these requirements, a collaborative practice agreement or supervision by a physician is generally required. Physician Assistants (PAs) in Utah operate under the supervision of a licensed physician. Utah Code Ann. § 58-70a-102 defines a PA as an individual licensed to practice under the supervision of a physician. The scope of practice for a PA is determined by the supervising physician's scope of practice and the PA's education, training, and experience, as outlined in a 'delegation of services agreement' filed with DOPL (Utah Admin. Code R156-70a-601). PAs cannot practice independently and must maintain a supervisory relationship. The supervising physician is ultimately responsible for the PA's actions. For other mid-level providers, such as Certified Registered Nurse Anesthetists (CRNAs) and Certified Nurse Midwives (CNMs), specific regulations govern their practice, often requiring physician collaboration or supervision depending on the service. In medspas, the delegation rules for medical assistants (MAs) are critical. MAs can perform delegated medical tasks that do not require independent medical judgment, under the direct supervision of a licensed physician or other qualified practitioner (e.g., NP, PA within their scope). Utah Admin. Code R156-1-301(4) outlines the general principle of delegation. Procedures like injectables (e.g., Botox, dermal fillers) or laser treatments, which constitute the practice of medicine, must be performed by a licensed physician, NP, or PA, or delegated to a qualified individual (e.g., RN) under appropriate supervision. Direct supervision, meaning the supervising practitioner is physically present on the premises and immediately available, is often required for higher-risk procedures. Companies must meticulously review the specific scope of practice for each professional type and ensure appropriate supervision and delegation protocols are in place, especially in multi-disciplinary settings or those involving advanced procedures.
Navigating Utah's Corporate Practice of Medicine (CPOM) doctrine necessitates careful business structuring, particularly for healthcare companies with non-clinician founders or investors. The Professional Corporation (PC) or Professional Limited Liability Company (PLLC) structure is essential for the clinical entity. Utah Code Ann. § 16-11-1 et seq. governs PCs, requiring all shareholders to be licensed professionals of the same profession. Similarly, Utah Code Ann. § 48-3a-101 et seq. allows for PLLCs, with ownership restricted to licensed professionals. For companies with non-clinician ownership or those seeking external investment, the PC-MSO (Professional Corporation – Management Services Organization) model is the predominant compliant structure. In this model, the PC/PLLC, owned by licensed professionals, employs the clinical staff and delivers professional medical services. A separate MSO, which can be owned by non-clinicians, provides all non-clinical administrative and management services to the PC/PLLC under a Management Services Agreement (MSA). These services typically include billing, scheduling, marketing, IT support, facility management, and HR. The MSA is critical and must be structured to avoid any violation of CPOM or fee-splitting prohibitions. Utah's fee-splitting rules, generally found within professional practice acts and administrative codes (e.g., Utah Admin. Code R156-67-501 for physicians), prohibit licensed professionals from sharing professional fees with unlicensed individuals or entities in exchange for patient referrals or other services that constitute improper inducement. The MSO's compensation must be a fixed fee, a cost-plus arrangement, or a fair market value percentage of gross revenues (not net profits), and must be clearly tied to the value of the administrative services provided, not to patient volume or the generation of professional fees. It cannot be contingent on the volume or value of referrals. The MSO cannot exercise control over clinical decision-making, hiring/firing of clinical staff, or setting professional fees. All clinical records and patient data must remain under the control of the PC/PLLC. Management services agreements should be reviewed by legal counsel experienced in Utah healthcare law to ensure compliance. For medspas, IV therapy clinics, and wellness centers, this structure is particularly vital. The physician (or other licensed practitioner) must be the ultimate authority for all medical services, and the clinical entity must be appropriately owned. Any arrangement that appears to allow an unlicensed entity to profit directly from the provision of medical services or to control clinical operations will likely be deemed non-compliant. Careful attention to the details of the MSA, the financial flow, and the delineation of responsibilities is paramount to mitigate regulatory risk.
Utah's regulatory landscape continues to evolve, with several key developments and ongoing legislative considerations impacting telehealth, CPOM, and prescribing. In the 2024 legislative session, House Bill 212, 'Telehealth Amendments,' was introduced and passed, further refining the definition of telehealth and ensuring continued payment parity for telehealth services. This bill aimed to solidify the permanence of many telehealth flexibilities that emerged during the COVID-19 pandemic, ensuring that telehealth remains a viable and reimbursed mode of care delivery beyond the emergency period. While not a complete overhaul, it demonstrates Utah's commitment to supporting telehealth. Regarding CPOM, there have been no significant legislative changes to relax the doctrine. DOPL continues to enforce existing regulations, and recent enforcement actions have primarily focused on unlicensed practice, improper delegation of medical procedures in settings like medspas, and instances where non-licensed individuals appeared to exert undue control over clinical operations. These cases reinforce the need for strict adherence to the PC-MSO model and careful structuring of MSAs. On the prescribing front, Utah has been closely monitoring federal DEA actions regarding controlled substance prescribing via telehealth. While the federal waivers have been extended through December 31, 2024 (and for established relationships, through December 31, 2025), Utah's state laws will continue to align with federal requirements. There has been ongoing discussion within the Utah Medical Board and Pharmacy Board regarding how to best integrate new federal rules once finalized, particularly concerning the in-person examination requirement for controlled substances. Utah continues its participation in interstate compacts, facilitating multi-state practice. The state is a member of the Interstate Medical Licensure Compact (IMLC), allowing eligible physicians to obtain licenses in multiple compact states more efficiently. Utah is also part of the Nurse Licensure Compact (NLC), enabling registered nurses and licensed practical nurses to practice in other compact states. These compacts significantly streamline the licensing process for telehealth providers seeking to serve Utah patients from out-of-state, provided they meet compact eligibility criteria. Companies should monitor the DEA's final rules on controlled substance prescribing via telehealth, as this will be the most significant federal development impacting prescribing practices in 2025-2026.
For healthcare companies entering or expanding into Utah, a structured approach to compliance is essential. Here's actionable guidance:
1. Licensing First:
2. CPOM-Compliant Structure:
3. Telehealth Protocols:
4. Prescribing Compliance:
5. Scope of Practice & Supervision:
6. Documentation & Auditing:
Common Pitfalls to Avoid:
Timeline Expectations: Licensing can take several weeks to months, especially for new applicants or those from non-compact states. Entity registration is quicker. Budget ample time for legal review of business structures and agreements (1-3 months).
This article outlines the Centers for Medicare & Medicaid Services (CMS) requirements for healthcare providers offering telehealth services, focusing on credentialing and Medicare enrollment. It details the specific regulations and flexibilities that impact providers seeking to bill Medicare for virtual care, emphasizing the importance of compliance for continued participation.
State dental boards are actively defining the scope and standards for teledentistry, impacting how dental professionals can provide remote care. These regulations often address patient-provider relationships, technology requirements, consent, and record-keeping, emphasizing parity with in-person care standards. Compliance is crucial for dental practices expanding into virtual services to avoid regulatory scrutiny.
The provision of IV vitamin therapy and hydration services via telehealth requires strict adherence to state-specific regulations regarding the establishment of a valid practitioner-patient relationship, physical examination requirements, and supervision protocols. Many states mandate an in-person initial examination or specific telehealth modalities to ensure patient safety and appropriate medical oversight for these invasive procedures. Healthcare businesses offering these services must meticulously review and comply with the medical practice acts and board rules of each state where they operate.
Medspas leveraging telehealth for oversight across multiple states face complex and varying medical director requirements. Understanding the specific state laws governing physician supervision, corporate practice of medicine, and telehealth regulations is crucial for compliance and avoiding legal pitfalls.
The FDA has issued multiple warnings and guidance regarding the use of compounded semaglutide and tirzepatide, emphasizing that these compounded versions are not FDA-approved and may pose risks. This regulatory stance significantly impacts telehealth weight loss programs that rely on these medications, highlighting critical compliance considerations for prescribers and pharmacies.
Full physician-led clinical encounters with prescribing authority — real provider-patient relationships, not just clearance visits.
Board-certified medical directors for telehealth platforms, medspas, IV therapy clinics, dental sleep medicine, chiropractic practices, and more.
Structured agreements between physicians and mid-level providers ensuring compliant care delivery.
Navigate Corporate Practice of Medicine laws with state-specific compliance frameworks and legal structures.
Systematic clinical documentation reviews ensuring quality standards and regulatory compliance.
Receive instant notifications when Utah changes healthcare regulations.
Subscribe to AlertsGet a customized compliance framework for your healthcare operations in Utah — telehealth, medspa, IV therapy, or brick-and-mortar. Our team will guide you through every regulatory requirement.